Skip to Main Content

NISH (NITAG Support Hub) 4: HPV OR Human Papillomavirus Vaccines: Useful general grey literature sources

This Library Guide is a collection of useful documents & evidence on the efficacy, effectiveness and impact of the HPV OR Papillomavirus vaccine to support NITAG members and other policy makers throughout Africa with making evidence-based recommendations

Grey literature

Dull, P. M., Achilles, S. L., Ahmed, R., Barnabas, R. V., Campos, N. G., Chirgwin, K., Cohen, J. A., de Sanjosé, S., Doorbar, J., Einstein, M. H., Emerson, C. I., Gottlieb, S. L., Hildesheim, A., Qiao, Y., Ruff, P., Sampson, J. N., Sasieni, P., Schiffman, M., Shin, H., … Kreimer, A. R. (2024). Meeting report: Considerations for trial design and endpoints in licensing therapeutic HPV16/18 vaccines to prevent cervical cancer. Vaccine, S0264-410X(24)00741-2. https://doi.org/10.1016/j.vaccine.2024.07.001

Waheed, D.-E.-N., Burdier, F. R., Eklund, C., Baussano, I., Mariz, F. C., Téblick, L., Mugo, N., Watson-Jones, D., Stanley, M., Baay, M., & Vorsters, A. (2023). An update on one-dose HPV vaccine studies, immunobridging and humoral immune responses—A meeting report. Preventive Medicine Reports35, 102368. https://doi.org/10.1016/j.pmedr.2023.102368

DHS Program: Demographic and Health Surveys, 2025. Suggestions for Monitoring New Vaccines, Schedules, and Target Groups in Household Surveys, DHS Program: Demographic and Health Surveys. United States of America. Retrieved from https://coilink.org/20.500.12592/xp9v3st on 17 Jul 2025. COI: 20.500.12592/xp9v3st.